Sinclair Pharma US, Inc.

Sinclair Pharma is a global medical aesthetics company specializing in the development and commercialization of injectable treatments and energy-based devices (EBD) for aesthetic medicine. Operating in over 55 countries with direct presence in key markets and a network of distributors, Sinclair manufactures a comprehensive portfolio of hyaluronic acid fillers, biostimulatory injectables, and advanced aesthetic devices designed for physicians and clinical professionals. The company's product lines include MaiLi (HA fillers), Lanluma, Ellanse, Primelase, V-Series, PerfectHA, CoolTech Define, Elysion Pro, and Enerjet, supporting a full aesthetic treatment journey from facial rejuvenation to body contouring. As a subsidiary of Huadong Medicine Company Limited (East China Pharmaceuticals), Sinclair combines scientific advancement with clinical efficacy to deliver results-driven solutions for aesthetic practitioners and their patients.